News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 109–144
- Matches
- 226
- Sources here
- 13
- Companies here
- 9
Active search
226 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Biomerica Inc (BMRA) Financial Health: Profitability & Balance Sheet Analysis
Biomerica Inc (BMRA) has a current financial score of 5.94, ranking 183 out of 199 in the Healthcare Equipment & Supplies industry. The company's financial status is robust, but its operating efficiency is low. Its latest quarterly revenue decreased by 11.80% year-over-year, and net …
Banco Comercial Portugues SA (BPCGY) (H1 2026) Earnings Call Highlights: Net Income Surges 12. ...
This article first appeared on GuruFocus. Release Date: July 30, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Net income increased by 12.7% year-on-year to EUR565.8 million in the first half of 2026, …
Atomera Inc (ATOM) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Atomera Inc (ATOM), detailing its current price momentum score of 5.72 and its ranking within the Semiconductors & Semiconductor Equipment industry. It highlights the stock's trading range between resistance at $7.09 and support at $3.84, suggesting suitability …
Earnings Preview: Atomera to Report Financial Results Post-market on August 04
This article announces that Atomera (ATOM) is scheduled to release its financial results after market close on August 4. Investors will be keen to see if the company can surpass the consensus EPS estimate of -$0.12, having missed estimates in the last two consecutive …
Biomerica Inc (BMRA) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Biomerica Inc (BMRA), detailing its current risk score of 2.65 and its beta value of 0.30. It covers various financial metrics including volatility, maximum drawdown, Sharpe Ratio, and liquidity. The report indicates that BMRA tends to underperform …
Biomerica Inc (BMRA) Valuation: PE, PB & Fair Value Analysis
The article provides a valuation analysis for Biomerica Inc (BMRA), stating its current valuation score is 7.66, ranking 139 out of 199 in the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of -0.99, noting its position relative to recent highs …
Agencia Comercial Spirits (Nasdaq: AGCC) completes $200M stock offering
Agencia Comercial Spirits Ltd. (Nasdaq: AGCC) has successfully completed a registered primary equity offering, raising $200 million in gross proceeds by selling 20 million Class A ordinary shares at $10.00 each to institutional investors. The company plans to use these net proceeds primarily to …
BMRA|Biomerica Inc|Price:1.500|Chg%:-0.090
This article provides an in-depth analysis of Biomerica Inc. (BMRA) stock, covering its market trends, key figures, financial indicators, and company overview. It highlights the company's strong fundamentals and growth potential despite recent stock market performance, and offers insights into its diagnostic and therapeutic …
BlackRock (OMER) discloses 5.96M Omeros Corp shares in amended 13G filing
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 5,961,792 shares of Omeros Corp common stock, which represents an 8.2% stake in the company. BlackRock exercises sole voting power over 5,835,368 shares and sole dispositive power over all 5,961,792 shares, …
Agencia Comercial Spirits Raises $200 Million to Fund Global AI Data Center Expansion
Agencia Comercial Spirits Ltd. (AGCC) successfully raised $200 million through a Nasdaq-listed offering of 20 million Class A shares at $10.00 each. The capital will primarily fund the expansion of AI computing centers in the United States, Japan, and Southeast Asia, including servers, hardware, …
Customers Bancorp Inc (CUBI) Institutional Confidence
Customers Bancorp Inc (CUBI) has an institutional shareholding score of 10.00, placing it first in the Banking Services industry. The institutional shareholding proportion is 101.19%, an 11.04% increase quarter-over-quarter. ETHSX is the largest institutional shareholder, holding 210.06K shares.
Biomerica Inc (BMRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Biomerica Inc (BMRA), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. The current price momentum score is 3.26, and the stock is trading between resistance at $1.75 and support …
Lawsuit probes Omeros over stock drop after EMA rejects drug approval
Pomerantz LLP is investigating Omeros Corporation for securities fraud following a significant 19.12% stock drop on June 26, 2026. This decline occurred after the European Medicines Agency issued a negative opinion regarding Omeros's drug narsoplimab. The investigation seeks to determine if Omeros misled investors …
Atomera Incorporated Revenue Breakdown – NASDAQ:ATOM
Atomera Incorporated's revenue breakdown shows that in the last fiscal year, the company generated $65,000 USD, a decrease from $135,000 USD in the prior year. The MSTcad Licensing and Related Consulting Services segment was the top-performing segment, contributing all of the revenue. Geographically, North …
ATOM|Atomera Inc|Price:4.825|Chg%:-0.425
This article provides a detailed financial summary of Atomera Inc (ATOM), including its stock performance, key financial indicators, and earnings reports. It presents quarterly and annual data for EPS, Revenue, Net Profit, Net Margin, Gross Margin, and Debt to Assets Ratio, along with balance …
H.C. Wainwright reiterates Omeros stock rating on rival trial miss
H.C. Wainwright maintained a Buy rating and $33.00 price target for Omeros Corp. (NASDAQ: OMER) after a competitor's clinical trial for Ultomiris/ravulizumab failed to meet its primary endpoint. This development reduces the competitive threat to Omeros's Yartemelea drug launch in the U.S., allowing investor …
Omeros Corp (OMER) Stock Score & Comprehensive Stock Analysis
TradingKey provides a comprehensive stock analysis for Omeros Corp (OMER), noting its stable fundamentals, high growth potential, and "fairly valued" status within the Biotechnology & Medical Research industry. The company, focused on developing therapeutics for immunologic disorders and cancers, has high institutional ownership and …
Atomera (ATOM) Projected to Announce Quarterly Earnings on Tuesday
Atomera (NASDAQ:ATOM) is projected to report its Q2 2026 earnings after market close on Tuesday, August 4th, with analysts forecasting a loss of $0.13 per share and $0.10 million in revenue. The company missed expectations in its previous quarter. Atomera shares opened at $5.25, …
Atomera Inc (ATOM) Financial Health: Profitability & Balance Sheet Analysis
Atomera Inc (ATOM) currently holds a financial score of 6.26, placing it 91st out of 105 in the Semiconductors & Semiconductor Equipment industry, indicating robust financial health despite low operating efficiency. The company's latest quarterly revenue surged by 175.00% year-over-year to $11.00K, and net …
Biomerica Inc (BMRA) Cash Flow
This article provides a detailed historical cash flow statement for Biomerica Inc (BMRA), including quarterly and annual data for operating, investing, and financing activities. It also defines these cash flow types and answers frequently asked questions regarding Biomerica's cash flow performance, capital expenditures, and …
Biomerica Inc (BMRA) Income Statement
This article provides the quarterly and annual income statement data for Biomerica Inc (BMRA), detailing revenue, costs, operating expenses, and net income figures across various fiscal periods. It also includes an FAQ section explaining how to interpret the income statement and defining key financial …
Customers Bancorp Inc (CUBI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article from TradingKey provides a revenue breakdown for Customers Bancorp Inc (CUBI). It indicates that relevant data regarding revenue by business segment and region for fiscal years 2019-2022 has not yet been disclosed by the company. The article displays CUBI's current trading information, …
CUBI Q2 Deep Dive: AI Investments and Deposit Growth Drive Strategic Progress
CUBI Q2 Deep Dive: AI Investments and Deposit Growth Drive Strategic Progress Regional banking company Customers Bancorp (NYSE:CUBI) fell short of the market's revenue expectations in Q2 CY2026, but sales rose 9.9% year on year to $227.3 million. Its non-GAAP profit of $2.05 per …
Omeros Corporation Revenue Breakdown – LS:A0NBFF
This page provides financial information for Omeros Corporation (LS:A0NBFF) on TradingView. It offers an overview of the company's financials, including statements, statistics, dividends, earnings, and segment breakdowns by source and country. The content appears to be a stub or a section of a larger …
AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights
H.C. Wainwright reiterated its 'Buy' rating on Omeros (OMER) after AstraZeneca's (AZN) Ultomiris failed its primary endpoint in a Phase 3 trial for transplant-associated thrombotic microangiopathy (TA-TMA). This setback is seen as a "clear positive" for Omeros, as it removes the primary near-term competitive …
Biomerica Inc (BMRA) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Biomerica Inc.'s (BMRA) dividend history and stock split events. It states that no dividends have been distributed in the past five years and lists one stock split event, a Merger 8→1, scheduled for April 16, 2025. The company's …
CUSTOMERS BANCORP INC : JP MORGAN RAISES TARGET PRICE TO $96 FROM $94
JP Morgan has raised its target price for Customers Bancorp Inc (CUBI.N) to $96 from the previous $94. This adjustment in the target price indicates a revised outlook on the bank's stock by the investment firm. The news was reported by Reuters.
Biomerica Inc (BMRA) Balance Sheet - Tradingkey.com
This article provides a detailed quarterly and annual balance sheet analysis for Biomerica Inc (BMRA). It presents extensive financial data including total equity, cash, receivables, inventory, current and non-current assets, liabilities, and shareholder equity over various fiscal quarters and years. The content also includes …